FibroGen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. 

CEO
Thane Wettig
CEOThane Wettig
Employees
486
Employees486
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1993
Founded1993
Employees
486
Employees486

FGEN Key Statistics

Market cap
37.53M
Market cap37.53M
Price-Earnings ratio
-0.27
Price-Earnings ratio-0.27
Dividend yield
Dividend yield
Average volume
1.57M
Average volume1.57M
High today
$0.3945
High today$0.3945
Low today
$0.3302
Low today$0.3302
Open price
$0.3323
Open price$0.3323
Volume
1.96M
Volume1.96M
52 Week high
$2.93
52 Week high$2.93
52 Week low
$0.29
52 Week low$0.29

FGEN News

TipRanks 2d
FibroGen Reports Strong Q3 Growth and Future Plans

FibroGen ( (FGEN) ) has released its Q3 earnings. Here is a breakdown of the information FibroGen presented to its investors. FibroGen, Inc. is a biopharmaceut...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.